Rebeca Echeverria-Chasco1, Marta Vidorreta2, Verónica Aramendia-Vidaurreta1, Nuria Garcia-Fernandez3, Gorka Bastarrika1, and Maria A. Fernandez-Seara1
1Radiology, Clinica Universidad de Navarra, Pamplona, Spain, 2Siemens Healthineers, Madrid, Spain, 3Nephrology, Clinica Universidad de Navarra, Pamplona, Spain
Synopsis
The main goal of this work was to optimize the robustness of pseudo continuous Arterial Spin Labeling (pCASL) to acquire renal images in CKD patients. The optimization was firstly carried out through numerical simulations, and a pCASL experiment in healhty volunteers to assess the veracity of the simulations. The results were in agreeement with the simulations (p-value = 0.04). For CKD patients, the numerical simulations were made to select the parameters that maximize the efficiency. The results for CKD patients and controls that show highest efficiencies are ratios 6-7 and Gave of 0.5-0.7 mT/m.
Introduction
Arterial
Spin Labeling (ASL)1 is a non-invasive and non-contrast MR imaging
technique which allows the quantification of renal blood flow (RBF). ASL has
been used to measure tissue perfusion in the kidneys in patients with Chronic
Kidney Disease (CKD), in which the renal function may be affected, showing a
reduced RBF2,3.
Pseudo-continuous
ASL4-5 (pCASL), is the recommended labeling strategy in brain ASL6,
as it provides higher SNR and a more controlled duration of the inverted bolus.
However, pCASL might suffer from efficiency losses due to magnetic field
variations at the labeling plane, in addition to being sensitive to pulsatile
blood flows with high velocities7-10.
The main goal of this work was to improve the robustness of pCASL to measure
RBF and detect dysfunctional changes in CKD patients.
The
optimization procedure was divided in two sections, in the first one, pCASL
labeling efficiency was optimized for young and healthy volunteers considering renal
conditions9, employing numerical simulations and testing the results
in an in-vivo experiment to assess the validity of the simulations, and in the second one, a study
with CKD patients and age-matched controls was performed to select the pCASL parameters
that can yield higher efficiencies.Materials and Methods
All participants were scanned in a 3T Skyra system (Siemens,
Erlangen, Germany), using an 18-channel body coil, after signing a written
informed consent.
Numerical Simulations validation
Blood Flow Characterization
Aortic blood flow was characterized in the
same position as the labeling plane was located9, using a
phase-contrast PC sequence (Fig. 1 c) in 15 volunteers (age=29±4y). Blood flow
profiles were calculated and averaged after matching the systolic peaks across
the volunteers. These data were used to compute the blood flow contribution of each
velocity for spins traversing the labeling plane for the total duration of a
complete cardiac cycle (Fig 2. a-b).
Numerical Simulation
Bloch equations were numerically integrated11 to compute
the inversion efficiency over a wide range of pCASL parameters (Fig. 1 a) for
spins flowing with the velocities previously measured and assuming field
inhomogeneities, with off-resonance frequencies7-9 between 0 and 500
Hz. Longitudinal magnetization was measured at 250 ms after crossing the center
of the labeling plane, corrected for T1 decay and used to compute inversion
efficiency for each velocity. The overall inversion efficiency was obtained taking
into account the blood flow contribution of each velocity and across
off-resonance frequencies. Efficiency maps were computed.
In vivo ASL Experiment
Six healthy volunteers (age=31±8y) were scanned to test the results
of the simulations. Eight unbalanced pCASL configurations were assessed
resulting from the combination of four average gradients (Gave) (0.4, 0.6, 0.8,
1.0 [mT/m]) and two ratios (R=Gmax/Gave) (7, 10), with identical readout
parameters (Fig. 1 b).
Images were registered using ANTS12, outliers were discarded
and the mean signal was calculated in a bilateral ROI including the kidneys for
each volunteer and pCASL configuration. A two-way analysis of variance (ANOVA)
was performed to test if there were significant differences in perfusion signal
across pCASL parameters.
pCASL Optimization for CKD Patients
Blood Flow Characterization and Numerical Simulation
Aortic flow was measured in 5 CKD patients stage 3-4 (age=78.6±6.6y)
and 6 aged matched healthy controls (age=75±3.9y). Blood flow measurements were
analyzed as previously described in young volunteers.
Numerical simulations were used to evaluate the pCASL efficiency
for the blood flow measured in CKD patients and age-matched controls under off-resonance
conditions. Efficiency maps were computed to select those pCASL parameters
which maximized the efficiency.Results
Numerical Simulations validation
Velocity profiles in healthy volunteers are shown in (Fig. 2
a), in which peak velocities of 124 cm/s are reached in systole. Fig. 2 b shows
the normalized contribution of each velocity to the total flow traversing the
labeling plane. Efficiency maps for on-resonance (Fig. 2 c) and off-resonance (Fig. 2 d), show that the highest efficiencies are achieved for Gave
values of 0.3-0.5 mT/m. On-resonance, the highest ratio yields the highest
efficiency, however to obtain a high efficiency in presence of field
inhomogeneities the ratio has to be reduced.
Perfusion maps in one volunteer are shown in Fig. 4 a, and Fig.
4 b, shows the averaged group results. These results are in agreement with the simulations.
ANOVA showed significant differences across Gave
values (p-value =0.04).
pCASL Optimization for CKD Patients
CKD and controls blood flow profiles and velocity contribution
curves are shown in Fig 5. a-d. Both CKD patients and controls, have similar
velocity profiles with peak velocities between 55 and 65 cms/s for each group,
which are almost 50% of the peak velocities in young volunteers.
Efficiency maps (Fig. 5 e-h) show that on resonance, high
efficiency values (over 0.8) are found for a wide range of parameters (ratios
over 5 and Gave higher than 0.2-0.3 [mT/m]), whereas when considering off-resonance,
the range of parameters that provide high efficiencies are narrower (ratios
between 5-7 and Gave values of 0.5-0.7 [mT/m]), although, interestingly, compared
to young volunteers, efficiency of pCASL is less sensitive to off-resonance, as
the blood flow velocities are much lower.Conclusion
To optimize the inversion efficiency of pCASL in studies of CKD,
Gave should be set to 0.5-0.7mT/m and the ratio of Gmax to Gave should be 6-7.Acknowledgements
Rebeca
Echeverria-Chasco received Ph.D. grant support from Siemens Healthcare Spain.References
1. Williams
DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion
using spin inversion of arterial water. Proc Natl Acad Sci USA 1992; 89: 212–
216.
2. Nery, F.;
Gordon, I.; Thomas, D.L. Non-Invasive Renal Perfusion Imaging Using Arterial
Spin Labeling MRI: Challenges and Opportunities. Diagnostics 2018, 8, 2.
3. Aghogho Odudu,
Fabio Nery, Anita A Harteveld, Roger G Evans, Douglas Pendse, Charlotte E
Buchanan, Susan T Francis, María A Fernández-Seara, Arterial spin labelling MRI
to measure renal perfusion: a systematic review and statement paper, Nephrology
Dialysis Transplantation,
Volume 33, Issue suppl_2, September 2018, Pages ii15–ii21
4. Dai W, Garcia D, De Bazelaire
C, Alsop DC. Continuous flow-driven inversion for arterial
spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med.
2008;
5. Wu WC, Fernández-Seara M, Detre JA, Wehrli
FW, Wang J. A theoretical and experimental investigation of the tagging
efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med.
2007;58(5):1020–7.
6. Alsop DC, Detre JA, Golay X, Günther M,
Hendrikse J, Hernandez-Garcia L, et al. Recommended implementation of arterial
spin-labeled Perfusion mri for clinical applications: A consensus of the ISMRM
Perfusion Study group and the European consortium for ASL in dementia. Magn
Reson Med. 2015;73(1):102–16.
7. Zhao L, Vidorreta M, Soman S, Detre JA,
Alsop DC. Improving the robustness of pseudo-continuous arterial spin labeling
to off-resonance and pulsatile flow velocity. Magn Reson Med.
2017;78(4):1342–51.
8. Jahanian H, Noll DC, Hernandez-Garcia L. B 0
field inhomogeneity considerations in pseudo-continuous arterial spin labeling
(pCASL): Effects on tagging efficiency and correction strategy. NMR Biomed.
2011;24(10):1202–9.
9. Echeverria-Chasco R,
Vidorreta M, Aramendia-Vidaurreta V, Bastarrika G, Fernández-Seara M.A. Optimization
of Pseudo Continuous Arterial Spin Labeling for renal ASL. International Society for Magnetic Resonance in Medicine;
11-16 May, 2019; Montreal, QC, Canada. 4954
10. Greer J.S, Wang Y, Pedrosa I, and Madhuranthakam
A.J. Pseudo-continuous arterial spin labeled renal perfusion imaging at 3T with
improved robustness to off-resonance. International Society for Magnetic
Resonance in Medicine; 11-16 May, 2019; Montreal, QC, Canada. 4959
11. Maccotta L, Detre J a, Alsop DC. The
efficiency of adiabatic inversion for perfusion imaging by arterial spin labeling.
NMR Biomed. 1997;10(4–5):216–21
12. Avants,
B. B., Tustison, N., & Song, G. (2009). Advanced normalization tools
(ANTS). Insight j, 2, 1-35.